Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial
Dartmouth–Hitchcock Medical Center · Duke University · +31 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
551
total citations
- FWCI
- 35.91
- Percentile
- 100%
- References
- 26
Citations per year
Authors
30- PEPaul E. HoltzheimerCorresponding
Dartmouth–Hitchcock Medical Center
- MMMustafa M. Husain
Duke University, The University of Texas Southwestern Medical Center
- SHSarah H. Lisanby
National Institute of Mental Health
- SFStephan F. Taylor
University of Michigan
- LALouis A. Whitworth
The University of Texas Southwestern Medical Center, Neurological Surgery
Topics & keywords
Topics
Keywords
- Depression (economics)
- Deep brain stimulation
- Medicine
- Treatment-resistant depression
- Adverse effect
- Randomized controlled trial
- White matter
- Clinical trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- NSNational Science Foundation
- BABrain and Behavior Research Foundation
- ALAbbott Laboratories
- AEAmerican Epilepsy Society
- PPfizer
- GGlaxoSmithKline
- MMedtronic
- BIBaxter International
- HFHope for Depression Research Foundation
- TPTakeda Pharmaceutical Company
- AAA. Alfred Taubman Medical Research Institute
- BSBoston Scientific Corporation
- JPJazz Pharmaceuticals
- SFStanley Foundation
- RDRare Disease Foundation
- NNeuroPace
- BBiotronik
- HLH. Lundbeck A/S
- NINational Institutes of Health
- DADefense Advanced Research Projects Agency
- SJSt. Jude Medical
- AAllergan
- GGGE Global Research
- CICanadian Institutes of Health Research
- NINational Institute on Aging
- NINational Institute of Mental Health
- NINational Institute on Drug Abuse
- NINational Institute of Neurological Disorders and Stroke
- JPJanssen Pharmaceuticals